166 related articles for article (PubMed ID: 10319756)
1. PET in lung cancer.
Coleman RE
J Nucl Med; 1999 May; 40(5):814-20. PubMed ID: 10319756
[TBL] [Abstract][Full Text] [Related]
2. Applications of PET in lung cancer.
Al-Sugair A; Coleman RE
Semin Nucl Med; 1998 Oct; 28(4):303-19. PubMed ID: 9800237
[TBL] [Abstract][Full Text] [Related]
3. Value of whole-body FDG PET in management of lung cancer.
Higashi K; Matsunari I; Ueda Y; Ikeda R; Guo J; Oguchi M; Tonami H; Yamamoto I
Ann Nucl Med; 2003 Feb; 17(1):1-14. PubMed ID: 12691125
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
Graeber GM; Gupta NC; Murray GF
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of positron tomography (PET) in lung cancer].
Kerik NE; Alexanderson-Rosas E; Fermon-Schwaycer S; Ruíz-Ramírez OL; Alonso-López F
Gac Med Mex; 2004; 140(5):525-9. PubMed ID: 15559234
[TBL] [Abstract][Full Text] [Related]
6. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R
Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
[TBL] [Abstract][Full Text] [Related]
7. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
8. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Gupta NC; Maloof J; Gunel E
J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
[TBL] [Abstract][Full Text] [Related]
9. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
11. Imaging in lung cancer: positron emission tomography scan.
Vansteenkiste JF
Eur Respir J Suppl; 2002 Feb; 35():49s-60s. PubMed ID: 12064681
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of positron emission tomography in diagnosing and staging of lung cancer].
Zhu ZH; Zhou Q; Li LY; Cui RX; Cheng WY; Li YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):365-8. PubMed ID: 12940078
[TBL] [Abstract][Full Text] [Related]
13. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
14. [The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
Ben-Nun A; Orlovsky M; Best AL; Bar Shalom R
Harefuah; 2006 Oct; 145(10):713-7, 784, 783. PubMed ID: 17111703
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions - own experience.
Opoka L; Kunikowska J; Podgajny Z; Szołkowska M; Błasińska-Przerwa K; Burakowska B; Oniszh K; Rudziński P; Bestry I; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2014; 82(3):198-205. PubMed ID: 24793147
[TBL] [Abstract][Full Text] [Related]
17. [Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Bury T; Corhay JL; Paulus P; Weber T; D'Harcour JB; Limet R; Rigo P; Radermecker MF
Rev Mal Respir; 1996 Jul; 13(3):281-6. PubMed ID: 8765921
[TBL] [Abstract][Full Text] [Related]
18. Thoracic FDG PET: state of the art.
Erasmus JJ; McAdams HP; Patz EF; Goodman PC; Coleman RE
Radiographics; 1998; 18(1):5-20. PubMed ID: 9460106
[TBL] [Abstract][Full Text] [Related]
19. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
20. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]